Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 32% ± 10% | |
lung | 14 studies | 33% ± 13% | |
kidney | 8 studies | 31% ± 9% | |
intestine | 8 studies | 28% ± 11% | |
eye | 6 studies | 32% ± 16% | |
liver | 6 studies | 34% ± 24% | |
placenta | 4 studies | 23% ± 5% | |
uterus | 4 studies | 36% ± 11% | |
brain | 4 studies | 29% ± 11% | |
pancreas | 3 studies | 24% ± 1% | |
bone marrow | 3 studies | 24% ± 6% | |
thymus | 3 studies | 34% ± 15% | |
lymph node | 3 studies | 31% ± 5% | |
breast | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 919.35 | 170 / 170 | 98% | 3.19 | 448 / 459 |
prostate | 100% | 1163.98 | 245 / 245 | 97% | 3.47 | 486 / 502 |
ovary | 100% | 763.18 | 180 / 180 | 95% | 2.94 | 410 / 430 |
bladder | 100% | 881.95 | 21 / 21 | 95% | 3.94 | 477 / 504 |
intestine | 100% | 999.01 | 966 / 966 | 94% | 3.32 | 493 / 527 |
esophagus | 100% | 988.34 | 1445 / 1445 | 92% | 1.84 | 169 / 183 |
thymus | 100% | 1427.17 | 653 / 653 | 91% | 2.83 | 553 / 605 |
adrenal gland | 100% | 1241.54 | 258 / 258 | 91% | 2.26 | 210 / 230 |
brain | 100% | 1055.64 | 2640 / 2642 | 91% | 2.96 | 643 / 705 |
pancreas | 99% | 618.54 | 326 / 328 | 92% | 2.35 | 163 / 178 |
stomach | 100% | 1047.39 | 359 / 359 | 90% | 2.72 | 256 / 286 |
breast | 100% | 1045.73 | 459 / 459 | 84% | 2.13 | 943 / 1118 |
lung | 100% | 1033.79 | 577 / 578 | 80% | 1.69 | 920 / 1155 |
liver | 100% | 870.85 | 226 / 226 | 75% | 1.65 | 305 / 406 |
kidney | 100% | 1277.96 | 89 / 89 | 73% | 1.69 | 656 / 901 |
skin | 100% | 959.86 | 1809 / 1809 | 64% | 1.34 | 303 / 472 |
adipose | 100% | 848.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.06 | 29 / 29 |
spleen | 100% | 1391.16 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.91 | 1 / 1 |
blood vessel | 100% | 894.41 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1199.50 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 791.85 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 823.97 | 916 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 2.14 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 70% | 1.23 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033617 | Biological process | mitochondrial cytochrome c oxidase assembly |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0051082 | Molecular function | unfolded protein binding |
Gene name | PET100 |
Protein name | Protein PET100 homolog, mitochondrial HCG2036585, isoform CRA_b (PET100 cytochrome c oxidase chaperone) PET100 cytochrome c oxidase chaperone |
Synonyms | hCG_2036585 C19orf79 |
Description | FUNCTION: Plays an essential role in mitochondrial complex IV maturation and assembly. . |
Accessions | ENST00000698397.1 A0A8V8TM67 A0A8V8TN53 A0A8V8TLP9 ENST00000698396.1 ENST00000456958.7 M0R022 ENST00000598540.6 M0QZ55 A0A0A0MSK2 ENST00000594797.6 ENST00000601406.5 P0DJ07 ENST00000698398.1 |